Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy and Safety of Nasopharyngeal Tube During Sedation

NCT: NCT07880002 · NOT_YET_RECRUITING

NCT IDNCT07880002
StatusNOT_YET_RECRUITING
Start Date2026-10-08
Completion2027-09-30
SponsorInternational Peace Maternity and Child Health Hospital (OTHER)
First posted
Last updated

Brief Summary

The goal of this randomized controlled study is to determine whether nasopharyngeal tube oxygenation could increase the fraction of inspired oxygen compared with standard oxygen during a sedated procedure with spontaneous breathing. The main question it aims to answer is: • Does nasopharyngeal tube oxygenation deliver higher fraction of inspired oxygen without increasing adverse events, compared with regular nasal cannula during sedation? Researchers will compare nasopharyngeal tube to regular nasal cannula to see if nasopharyngeal tube oxygenation deliver higher fraction of inspired oxygen. Participants will: • Receive regular nasal cannula or nasopharyngeal tube

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑